Added to YB: 2025-08-13
Pitch date: 2025-08-11
FLGT [neutral]
Fulgent Genetics, Inc.
+12.52%
current return
Author Info
Company Info
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
Market Cap
$724.3M
Pitch Price
$20.68
Price Target
N/A
Dividend
N/A
EV/EBITDA
1.40
P/E
-16.70
EV/Sales
-0.19
Sector
Health Care Providers and Services
Category
growth
A Primer on Fulgent Genetics
FLGT (overview): Diagnostic & emerging therapeutic co. Lab biz offers comprehensive pathology & genetic testing; proprietary tech platform enables broad menu & rapid test dev. Therapeutic biz developing cancer nano-delivery platform w/ 2 candidates: FID-007 (Ph2) & FID-022 (Ph1). Competitive market; strong IP portfolio. $62.6M (22%) revenue from one customer. Facing HRSA audit of $548.9M COVID test reimbursements.
Read full article (5 min)